Screening for the Prevention of Cervical Cancer in the Era of Human Papillomavirus Vaccination: An Australian Perspective

Publisher： Karger

E-ISSN： 1938-2650|55|4|307-312

ISSN： 0001-5547

Source： Acta Cytologica, Vol.55, Iss.4, 2011-07, pp. : 307-312

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Addressing Confusion about the Risks and Benefits of Co-Testing versus Human Papillomavirus Testing for Cervical Cancer Screening

By  

Acta Cytologica, Vol. 61, Iss. 3, 2017-05 ,pp. : 252-252

Karger

Access to resources Recommend Favorite

Association of Schistosoma haematobium and Human Papillomavirus in Cervical Cancer

By  

Acta Cytologica, Vol. 54, Iss. 2, 2011-02 ,pp. : 205-208

Karger

Access to resources Recommend Favorite

Screening for the Prevention of Cervical Cancer in Australia: Time Is of the Essence

By  

Acta Cytologica, Vol. 56, Iss. 3, 2012-04 ,pp. : 330-332

Karger

Access to resources Recommend Favorite

Role of p16INK4a Cytology Testing as an Adjunct to Enhance the Diagnostic Specificity and Accuracy in Human Papillomavirus-Positive Women within an Organized Cervical Cancer Screening Program

By  

Acta Cytologica, Vol. 56, Iss. 5, 2012-09 ,pp. : 506-514

Karger

Access to resources Recommend Favorite

Human Papillomavirus DNA and Liquid-Based Cervical Cytology Cotesting in Screening and Follow-up Patient Groups

By  

Acta Cytologica, Vol. 50, Iss. 6, 2011-02 ,pp. : 627-631

Karger

Access to resources Recommend Favorite